Kinvard Bio Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Grant
- Financing Rounds
-
2
Kinvard Bio General Information
Description
Developer of antibiotics intended to combat multidrug-resistant bacterial infections. The company offers rational drug design and a proprietary synthetic chemistry platform to create a differentiated class of ribosome-targeting antibacterials, including oxepanoprolinamides, enabling clients to address the critical global health threat of antimicrobial resistance and provide urgently needed treatment options for patients with challenging acute and chronic bacterial infections.
Contact Information
Website
www.kinvardbio.comCorporate Office
- Raleigh, NC
- United States
Corporate Office
- Raleigh, NC
- United States
Kinvard Bio Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Kinvard Bio Signals
Kinvard Bio Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Kinvard Bio FAQs
-
When was Kinvard Bio founded?
Kinvard Bio was founded in 2024.
-
Where is Kinvard Bio headquartered?
Kinvard Bio is headquartered in Raleigh, NC.
-
What is the size of Kinvard Bio?
Kinvard Bio has 7 total employees.
-
What industry is Kinvard Bio in?
Kinvard Bio’s primary industry is Drug Discovery.
-
Is Kinvard Bio a private or public company?
Kinvard Bio is a Private company.
-
What is Kinvard Bio’s current revenue?
The current revenue for Kinvard Bio is .
-
Who are Kinvard Bio’s investors?
CARB-X and Kineticos Life Sciences Management have invested in Kinvard Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process